Research / LUNG / Fundamental state Inspectable configuration
State dimensions Filing 0001127537-26-000025 General Corporate
Debt relative to revenue 70th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.debt_to_revenue
181.25% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.04% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-49.05% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-8.66% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 60th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
79.23% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
77.94% · CORE · VALID
Operating margin 80th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-62.94% · CORE · VALID
R&D intensity 70th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
23.80% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
20.09% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 12 states History building
Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/8 normalized Level 3 Mar 31, 2024 0/8 normalized Level 3 Jun 30, 2024 0/8 normalized Level 3 Sep 30, 2024 0/9 normalized Level 3 Dec 31, 2024 0/9 normalized Level 3 Mar 31, 2025 0/9 normalized Level 3 Jun 30, 2025 0/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 8/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 40.99%
Current 181.25%
Delta 140.26% Capex Intensity Decreased
Previous 0.50%
Current 0.04%
Delta -0.46% Cash Generation Decreased
Previous -35.78%
Current -49.05%
Delta -13.27% Growth Decreased
Previous 8.01%
Current -8.66%
Delta -16.67% Inventory Pressure Increased
Previous 17.51%
Current 79.23%
Delta 61.72% Margin Increased
Previous 74.19%
Current 77.94%
Delta 3.75% Profitability Decreased
Previous -59.30%
Current -62.94%
Delta -3.64% R And D Intensity Increased
Previous 21.54%
Current 23.80%
Delta 2.26% Sbc Intensity Decreased
Previous 23.46%
Current 20.09%
Delta -3.37% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.